A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...

Independence Blue Cross has begun excluding coverage for 18 months for therapies — but not cancer drugs — that have an ...

Deramiocel is a cell therapy that has healing effects in muscle cells. If approved, deramiocel would be a once-quarterly ...

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Regenerative medicine focuses on repairing damaged skin and bringing back melanocytes, the cells that give skin its color.

Anna Podolanczuk, M.D., M.S., discusses how the differential diagnosis for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) is approached, the importance of early diagnosis ...

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.

A systematic review and meta-analysis found some supporting evidence for transdermal anti-inflammatory patches, but the ...

Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in ...

FDA officials have set a review date of June 30, 2025, to review avutometinib in combination with defactinib to treat ...